REGISTERED
on 23 Jan 2024
Last Applicant/ Owned by
FRIEDRICH-MIESCHER-STR. 15
T�BINGEN
DE
72076
Serial Number
97229623 filed on 20th Jan 2022
Registration Number
7289725 registered on 23rd Jan 2024
Correspondent Address
Jennifer Fraser
Filing Basis
No Filing Basis
Disclaimer
NO DATA
THE RNA PRINTER
(Based on 44(e)) Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical scientific testing of macromolecules (Based on 44(e)) Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allerg Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
(Based on 44(e)) Medical and veterinary services, in particular for therapeutic and preventative treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
(Based on 44(e)) Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical scientific testing of macromolecules
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
(Based on 44(d) Priority Application) Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
(Based on 44(e)) Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovacular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment of infectious diseases, allergies, autoimmune disorder and tumour diseases, for treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparations, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Health care products, namely, bacterioligical, or bacterial, or vitamin, or sanitary preparations for medical use; Dietetic substances adapted for medical use, in particular substances for food supplements
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
(Based on 44(e)) Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97229623
Mark Type
No Service Mark
Attorney Docket Number
No 067249-0059
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Dec 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 23rd Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Jan 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
| 18th Oct 2023 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| 27th Sep 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 27th Sep 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 27th Sep 2023 | ASSIGNED TO LIE |
| 08th May 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 08th Nov 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 08th Nov 2022 | NON-FINAL ACTION E-MAILED |